Promising outlook for frontline blinatumomab in Ph+ ALL
Acute lymphoblastic leukemia (ALL) is currently treated with a regimen of drugs that, while effective to an extent, could be improved upon. In this interview, Giovanni Martinelli, MD, of the Istituto ...
Author: VJHemOnc
Added: 07/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts